Surface antimicrobial coating to prevent bacterial biofilms
表面抗菌涂层可防止细菌生物膜
基本信息
- 批准号:9388956
- 负责人:
- 金额:$ 7.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-01 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAntibiotic ResistanceAntibiotic TherapyAntibioticsAntimicrobial EffectBacteriaBacterial InfectionsBlood Vessel ProsthesisCardiacCathetersCellsChargeChemicalsDataDatabasesDevelopmentDevicesEnvironmentEvolutionFamilyGlycineGram-Negative BacteriaHospitalsHumanImmobilizationInfectionLaboratoriesLeadLifeLimb structureLinkLocationMedicalMedical DeviceMembraneMethodsMicrobial BiofilmsModelingNosocomial InfectionsOutcomePainPatientsPeptidesPolyethylene TerephthalatesPolymersPositioning AttributePostdoctoral FellowProcessPropertyReportingResearchResearch PersonnelResearch Project GrantsResistanceResortStaphylococcus aureusSuperbugSurfaceTechnologyTestingTimeToxic effectWorkantimicrobialantimicrobial peptidebacterial communitybacterial resistancebasecareercostdesignflexibilityimprovedinnovationinterestmedical implantmimeticsnatural antimicrobialnovelpathogenpeptide structurepreventproduct developmentprotein aminoacid sequencesuccesstraining opportunity
项目摘要
Project Summary
Implant medical devices are widely utilized as an essential support to patients. It is projected that
many people will use at least one such device during their life time. However, there are medical issues
with these devices such as bacterial infection. In particular, the formation of bacterial biofilms in implant
medical devices further complicates the problem. Biofilms are bacterial communities that work together to
escape the killing by the host or antibiotics. Currently, there is no treatment for such biofilms on medical
devices and the last solution is to replace the infected ones. Such a replacement is costly and painful,
however. Therefore, the objective of this proposal is to develop novel antimicrobial peptides and
immobilization technologies that prevent bacterial biofilm formation on polymer materials of medical
significance. Unlike traditional antibiotics, antimicrobial peptides remain potent after millions of years'
evolution. We hypothesize that the immobilization of short antimicrobial peptides of varying activities can
prevent biofilm formation on the polyethylene terephthalate (PET) surface. To test our hypothesis, we
have designed the following specific aims: (1) To optimize the short antimicrobial peptide by sequence
permutation; and (2) To immobilize the optimized peptide to the polyethylene terephthalate surface. We
are well prepared to pursue this project. We have obtained preliminary results that support the feasibility
of this research in the PI's laboratory. The anticipated outcomes of this R03 project are two fold. First,
this project will lead to a family of short peptides with varying activity against superbugs. Second, the
development of novel peptide immobilization technology will bring forth new possibilities to patients who
are in need of new implant medical devices with improved properties. Finally, the project also provides an
excellent training opportunity to the PI's postdoctoral fellow who will pursue an independent career in this
direction.
项目摘要
植入医疗设备被广泛用作对患者的基本支持。预计
许多人一生中将至少使用一种这样的设备。但是,有医疗问题
使用这些设备,例如细菌感染。特别是,植入物中细菌生物膜的形成
医疗设备进一步使问题复杂化。生物膜是共同努力的细菌群落
避开宿主或抗生素的杀戮。目前,这种生物膜在医学上没有治疗
设备和最后一个解决方案是替换受感染的解决方案。这样的替代品是昂贵和痛苦的,
然而。因此,该提议的目的是开发新型抗菌肽和
固定技术可以防止在医学的聚合物材料上形成细菌生物膜
意义。与传统的抗生素不同,抗菌肽在数百万年后保持有效
进化。我们假设固定在不同活动的短抗菌肽可以
防止在聚乙烯二苯二甲酸酯(PET)表面形成生物膜。为了检验我们的假设,我们
已经设计了以下特定目的:(1)按顺序优化短抗菌肽
排列; (2)将优化的肽固定在聚对苯二甲酸酯表面上。我们
已经准备好追求这个项目。我们获得了支持可行性的初步结果
在PI实验室的这项研究中。该R03项目的预期结果是两个倍。第一的,
该项目将导致一个短肽家族对超级细菌的活动有所不同。第二,
新型肽固定技术的开发将为患者带来新的可能性
需要具有改进特性的新植入医疗设备。最后,该项目还提供了
Pi的博士后研究员的绝佳培训机会,他们将在此领域从事独立职业
方向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUANGSHUN WANG其他文献
GUANGSHUN WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUANGSHUN WANG', 18)}}的其他基金
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds
用于治疗慢性伤口生物膜的新型 Janus 型抗菌敷料
- 批准号:
10389108 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds
用于治疗慢性伤口生物膜的新型 Janus 型抗菌敷料
- 批准号:
10439451 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds
用于治疗慢性伤口生物膜的新型 Janus 型抗菌敷料
- 批准号:
10030925 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds
用于治疗慢性伤口生物膜的新型 Janus 型抗菌敷料
- 批准号:
10212426 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds
用于治疗慢性伤口生物膜的新型 Janus 型抗菌敷料
- 批准号:
10653860 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
Human Cathelicidin-Based Novel Antimicrobial Peptides
基于人导管素的新型抗菌肽
- 批准号:
8116778 - 财政年份:2010
- 资助金额:
$ 7.53万 - 项目类别:
相似国自然基金
基于高通量测序和培养组学的伴侣动物-人抗生素抗性基因分布特征及传播研究
- 批准号:82373646
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
手性酰胺类农药污染的农业土壤中抗生素抗性基因传播扩散的对映选择性机制
- 批准号:42377238
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
猪粪水热炭对红壤-蔬菜系统中抗生素抗性基因的风险控制及其机理
- 批准号:42307038
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
蚯蚓-菌根协同消减抗生素抗性基因的微生物驱动机制
- 批准号:32301448
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生物炭对厌氧膜生物反应器抑制畜禽养殖废水中抗生素抗性基因的调控作用和机制
- 批准号:52300210
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
ANAEROBE 2022: the 16th Biennial Congress of the Anaerobe Society of the Americas (ASA)
厌氧菌 2022:第 16 届美洲厌氧菌协会 (ASA) 双年度大会
- 批准号:
10464618 - 财政年份:2022
- 资助金额:
$ 7.53万 - 项目类别:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
INSPIRE(智能管理提示改善患者实时经验性抗生素选择):针对腹内、皮肤和软组织感染的 INSPIRE-ASP 试验
- 批准号:
10198711 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
INSPIRE(智能管理提示改善患者实时经验性抗生素选择):针对腹内、皮肤和软组织感染的 INSPIRE-ASP 试验
- 批准号:
10018193 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
INSPIRE(智能管理提示改善患者实时经验性抗生素选择):针对腹内、皮肤和软组织感染的 INSPIRE-ASP 试验
- 批准号:
10631986 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别:
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
INSPIRE(智能管理提示改善患者实时经验性抗生素选择):针对腹内、皮肤和软组织感染的 INSPIRE-ASP 试验
- 批准号:
10418669 - 财政年份:2020
- 资助金额:
$ 7.53万 - 项目类别: